Paras Healthcare IPO Review: Growing Occupancy, Improving Margins – Should You Subscribe?

Paras Healthcare IPO opens on 21 October 2026 and closes on 23 October 2026. FY26 income grew 24.10%, virtually completely from extra sufferers quite than increased costs. EBITDA margin rose from 11.91% to twenty.60%, pushed by working leverage and a fall in physician and overhead prices.

The margins look spectacular, however the money circulate tells a special story. For three straight years, Paras Healthcare has spent extra on growth than it really earned from operations—relying closely on borrowings to fund the shortfall. Let’s break down the Paras Healthcare IPO evaluation and resolve: is it a purchase, or an keep away from?

Paras Healthcare IPO Details

Two-thirds of the difficulty is OFS, so many of the cash goes to present holders.

Paras Healthcare IPO Review: Business Overview

Paras Health operates eight hospitals with 2,211-bed capability, of which 1,502 are operational. Six specialities (cardiac, oncology, neuro, gastro, orthopaedics, renal) generate 74.70% of income. The hospitals sit in Tier-2 markets for probably the most half, which contributed 68.18% of FY26 income.

Revenue per hospital is the product of two issues, affected person days and income per affected person day (ARPOB):

In FY26, occupied mattress days grew 25.81% whereas ARPOB slipped 1.44%. In Q1 FY27, mattress days grew 25.89%, and ARPOB rose 1.41%. The progress engine is filling beds at hospitals that opened not too long ago.

ARPOB at these hospitals is decrease than on the flagship. Gurugram earns INR 74,911.63 per day, Kanpur INR 38,534.82 and Darbhanga INR 22,189.04. Srinagar’s ARPOB fell from INR 67,007.19 in FY24 to INR 36,532.56 in FY26 as occupancy rose, which suggests extra quantity at decrease realisations. A shift in payor combine probably explains a part of it. Government schemes went from 29.76% of income in FY24 to 43.63% in Q1 FY27, and self-pay fell from 40.63% to 31.30%.

The Margin Story

EBITDA margin on income rose by roughly 8.81 factors between FY25 and FY26. Each price line as a share of income from operations reveals the place it got here from:

The incremental numbers are robust. FY26 income rose INR 311.89 crore and EBITDA rose INR 179.12 crore, an incremental margin of 57.43%. That is what a high-fixed-cost hospital community seems like when beds fill.

Two of those features want a more in-depth look. Outsourced medical companies fell from INR 49.60 crore to INR 25.27 crore after the corporate took its radiology enterprise in-house from ClearMedi. That price has moved into different strains akin to depreciation, so it’s a partial reclassification. Loss allowance on receivables additionally fell from INR 20.40 crore to INR 9.70 crore.

In Q1 FY27, the supplies ratio fell from 27.73% to 24.48%. The RHP doesn’t clarify it, and it’s the line to look at within the subsequent outcomes.

Paras Healthcare IPO Analysis: Hospital Cohorts and Issue Objectives

Mature hospitals nonetheless produce 67.06% of income, however their progress has slowed from 16.70% in FY26 to eight.91% in Q1 FY27. Gurugram is almost full at 89.11% occupancy on 235 operational beds, so there’s little room to develop with out new capability. That is the logic behind the 300-bed Gurugram II hospital.

Patna added 40 operational beds, taking the entire from 269 to 309. Q1 occupancy there slipped from 82.78% to 72.93%, and mattress days grew only one.10%. CRISIL data Medanta with roughly 600 to 650 beds in Patna. Still, Patna grew income 27.97% in FY26 and runs a wholesome 73.16% occupancy.

Headroom is giant. About 709 beds will not be but operational, together with roughly 300 in Kanpur. Occupied beds in Q1 had been about 1,047, or 47.36% of the two,211 complete capability.

Rent can be turning into lighter as a share of income on the fixed-rent hospitals:

Use of proceeds:

Paras Healthcare IPO Valuation

Paras trades at a better P/E (171.09x) than the listed friends on this desk, with KIMS subsequent at 116.41x and Jupiter Lifeline at 42.92x. The cause is the earnings base: FY26 revenue of INR 43.83 crore got here proper after a loss in FY25, so the a number of sits on a small, not too long ago turned-positive quantity.

On returns, Paras’s RoNW of 12.98% is according to the group, above KIMS (11.01%) and Aster (9.70%), and just under Jupiter (13.41%). The case for the value rests on progress: income rose 24.10% in FY26, occupancy is at 69.72% in Q1 FY27, and about 709 beds are but to grow to be operational. If earnings scale as these beds fill, the a number of will look totally different on subsequent yr’s revenue.

Points To Track

• Expansion retains consuming money, and the debt lower is just partial.
• Between FY24 and FY26, operations generated INR 342.18 crore whereas capex was INR 503.64 crore, and borrowings stuffed the hole. The IPO repays INR 375 crore, however INR 513.89 crore of borrowings stay (adjusted debt-to-equity 1.15x). Gurugram II and Ludhiana will once more be funded from inner accruals and financial institution loans, and their undiscounted lease commitments alone are INR 1,054.78 crore. Finance prices had been INR 115.98 crore in FY26 in opposition to EBITDA of INR 335.58 crore. However, EBITDA lined finance prices 2.89x in FY26 and three.75x in Q1 FY27, up from 1.72x in FY25.
• Part of the margin bounce might not repeat.
• EBITDA margin rose from 11.91% to twenty.60% in FY26. Doctor retainers and advisor charges, the most important price line, fell from 27.74% to 24.54% of income, which is value about INR 51.39 crore in opposition to FY26 revenue earlier than tax of INR 76.03 crore. Medical skilled attrition was 61.24% in FY26, in order that ratio can transfer again. Some of the acquire can be one-off: transferring radiology in-house shifted price into different strains, and the loss allowance on receivables halved.
• Government payors deliver quantity however slower money.
• Government schemes and PSUs went from 29.76% of income in FY24 to 43.63% in Q1 FY27, and the charges are set by the federal government. The internet receivables is at about 50.50 days of income in FY24 and about 86.60 days by 30 June 2026. The FY26 rise absorbed INR 124.68 crore of working money.

Final Words

Paras Healthcare’s occupancy is rising and debt will fall. Two issues resolve how a lot of that reaches shareholders: whether or not government-scheme collections preserve tempo as that share of income grows, and whether or not Gurugram II and Ludhiana refill earlier than their lease commitments begin to weigh on margins.

Disclaimer: Paras Healthcare IPO evaluation is for informational functions solely and isn’t monetary recommendation. Always seek the advice of an authorized monetary advisor earlier than making any funding selections.

Rajat Bhati is an engineer by coaching (B.E.) with seven years within the inventory market. He covers fairness analysis, technical evaluation, IPO valuations and danger administration at IPO Central, and maintains the year-wise IPO tables and the ASBA and bidding-rule explainers. His intention is to offer traders clearer, data-backed selections quite than ideas.